Reduction in Risk of Heart Disease and Stroke Heart disease and stroke are two of the leading causes of death worldwide
Semaglutide treatment significantly improved alanine aminotransferase (ALT) (serum glutamic-pyruvic transaminase [SGPT]) levels, along with reductions in the aspartate aminotransferase to platelet ratio index (APRI) score, liver fat content and liver stiffness
[DOI] [PubMed] [Google Scholar] 25.Kosiborod M.N., Deanfield J., Pratley R., Borlaug B.A., Butler J., Davies M.J., Emerson S.S., Kahn S.E., Kitzman D.W., Lingvay I., et al
Summary: Protein Is the Foundation of Muscle Protection on GLP-1 Understanding how much protein on GLP-1 you need is not a minor detail